A multinational study presented at the European Academy of Dermatology and Venereology (EADV) Congress 2026 has found that people taking popular GLP-1 medications for weight loss and type 2 diabetes were more than four times as likely to report nail…
register or log in to get more services such as weather report, extended news articles and web search